CLINICAL_TRIALS
trial_result
· 2023-08-04
Clinical Trial Update: Safety Study of Danazol With Plasma Exchange and Steroids for the Treatment of Thrombotic Thrombocytopenic Purpura (TTP) [Phase 2]
Summary
This Phase 2 safety study evaluating danazol in combination with plasma exchange and steroids for thrombotic thrombocytopenic purpura was terminated; results ha…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Thrombotic Thrombocytopenic Purpura | Phase 2 | Status: TERMINATED | Results posted: 2023-08-04